Rare embryonic tumor of the central nervous system – neuroblastoma with FOXR2-activation
نویسندگان
چکیده
Introduction . The development of technologies for molecular genetic typing tumors the central nervous system (CNS) has significantly increased specificity traditional histological and immunohistochemical research methods. As a result, completely new variants have appeared, as well improved results treatment with long-term favorable prognosis. Thanks to biomarkers, among morphologically similar small-cell embryonic CNS tumors, extremely rare been identified: ETMR (embryonic tumor multiple rosettes C19MC), NB-FOXR2 (CNS neuroblastoma (NB) FOXR2-activation), EFT-CIC (tumor sarcoma family alteration), HGNET-MN1 (neuroepithelial high grade MN1 HGNET-BCOR BCOR alteration). aim study was assess historical prerequisites emergence nosological form “CNS NB FOXR2- activation”, presentation own diagnostics children this tumor. Materials methods diagnosis 7 patients FOXR2-activation were studied. Tumor identification carried out using DNA methylation technique profiles Heidelberg (Germany) brain classifier (www.molecularneuropathology.org), which recently become available in Russia. Results discussion Based on review international experience, evolution appearance classification clinical features are presented. authors present their FOXR2-activation. Conclusion Biomarkers proposed differential PNET-like children. Due children, it became clear that such patients, provided protocol is adequately followed, quite satisfactory survival results.
منابع مشابه
Exomic Sequencing of Four Rare Central Nervous System Tumor Types
A heterogeneous population of uncommon neoplasms of the central nervous system (CNS) cause significant morbidity and mortality. To explore their genetic origins, we sequenced the exomes of 12 pleomorphic xanthoastrocytomas (PXA), 17 non-brainstem pediatric glioblastomas (PGBM), 8 intracranial ependymomas (IEP) and 8 spinal cord ependymomas (SCEP). Analysis of the mutational spectra revealed tha...
متن کاملNeuroblastoma presenting as central nervous system disease.
Neuroblastoma may be extremely difficult to recognize, particularly when the tumor presents as a primary central nervous system disease. Central nervous system involvement may be considered as primary intracerebral neuroblastoma, metastases to the cranium from an occult primary, primary intraorbital neuroblastoma originating in the ciliary ganglion, metastatic intraorbital neuroblastoma from an...
متن کاملADENOSINE IN THE CENTRAL NERVOUS SYSTEM
Besides being a metabolite of nucleotides like ATP, adenosine is a mediator of neuronal function in the central nervous system. Its actions are mediated by at least three extracellular receptors. In this review different aspects of adenosine such as biosynthesis, release, inactivation and its receptors are discussed. It also covers pre- and postsynaptic effects as well as postreceptor mecha...
متن کاملactivation of microglial cells: the bridge between the immune system and pain in central nervous system
background : pain is one of the main protests of inflammatory diseases, hence, understanding the mechanisms which involved in the induction and persistence of pain is essential. microglia is a contributing factor in the onset and maintenance of inflammation. increased microglial activation increases the level of central pro-inflammatory cytokines and the development of central sensitization f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rossijskij žurnal detskoj gematologii i onkologii
سال: 2022
ISSN: ['2413-5496', '2311-1267']
DOI: https://doi.org/10.21682/2311-1267-2022-9-2-11-21